Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.

Disease modifying therapies (DMTs) reduce the frequency of relapses and accumulation of disability in multiple sclerosis (MS). Long-term persistence with treatment is important to optimize treatment benefit. This long-term, cohort study was conducted at the Calgary MS Clinic. All consenting adults w...

Full description

Bibliographic Details
Main Authors: Simon Zhornitsky, Jamie Greenfield, Marcus W Koch, Scott B Patten, Colleen Harris, Winona Wall, Katayoun Alikhani, Jodie Burton, Kevin Busche, Fiona Costello, Jeptha W Davenport, Scott E Jarvis, Dina Lavarato, Helene Parpal, David G Patry, Michael Yeung, Luanne M Metz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395027?pdf=render

Internet

http://europepmc.org/articles/PMC4395027?pdf=render

Similar Items